Wedbush Maintains Neutral on Replimune Group, Raises Price Target to $9
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsPrice Target
Wedbush analyst Robert Driscoll maintains Replimune Group (NASDAQ:REPL) with a Neutral and raises the price target from $6 to $9.
Wedbush analyst Robert Driscoll maintains Replimune Group (NASDAQ:REPL) with a Neutral and raises the price target from $6 to $9.